12/19
11:46 am
acet
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
11/18
12:38 pm
acet
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
10/16
02:34 pm
acet
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
9/30
02:03 pm
acet
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
Adicet Bio, Inc. (NASDAQ: ACET) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
9/30
09:01 am
acet
Adicet Bio, Inc. (NASDAQ: ACET) is now covered by analysts at Guggenheim. They set a "buy" rating and a $7.00 price target on the stock.
Low
Report
Adicet Bio, Inc. (NASDAQ: ACET) is now covered by analysts at Guggenheim. They set a "buy" rating and a $7.00 price target on the stock.
9/30
09:01 am
acet
Adicet Bio, Inc. (NASDAQ: ACET) is now covered by analysts at Guggenheim. They set a "buy" rating and a $7.00 price target on the stock.
Low
Report
Adicet Bio, Inc. (NASDAQ: ACET) is now covered by analysts at Guggenheim. They set a "buy" rating and a $7.00 price target on the stock.